Open original FDA record ↗Recall record
- FDA identifier
- Z-0905-2025
- Company in FDA record
- Olympus Corporation of the Americas
- FDA classification date
- Jan 16, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Potential for inadvertent retention of biomaterial when the reprocessing procedure is not performed as instructed, so as not completely removing and disassembling the device.
Source facts
- Action
- Olympus notified consignees on about 12/18/2024 via letter. Consignees were instructed to utilize alternative devices to the MAJ-891 according to the provided compatibility table provided, ensure all personnel are completely knowledgeable and thoroughly trained on the content of this letter and the MAJ-891 reprocessing instructions, acknowledge receipt of the letter through the Olympus portal, https://olympusamerica.com/recall, and notify customers if the units have been further distributed. Additionally, Olympus will contact customers to schedule a mutually beneficial time for an Olympus Field Representative to visit each facility and review the contents of this letter and the MAJ-891 reprocessing instructions.
- Initiated
- 2024-12-18
- Root cause
- Labeling design
- Distribution
- US Nationwide Distribution
- Recall number
- Z-0905-2025
- Recall status
- Open, Classified
- CDRH record ID
- 211489
- FDA classified
- 2025-01-16
- Recall event number
- 95898